20353 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
Sub-classes:Heteroarylsulfonyl Compounds As USP18 Inhibitors
#2USE OF APICIDIN COMBINED WITH BEVACIZUMAB IN PREPARING DRUG FOR TREATING CERVICAL CANCER
#3Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristics
#4PHARMACEUTICAL FORMULATIONS
#5QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF
#6TETRAHYDROISOQUINOLINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUND, AND USE THEREOF
#7METHOD AND TREATMENT FOR OSTEOARTHRITIS AND DISEASES OF CHONDROCYTE HYPERTROPHY
#8MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES
#9NEW CRYSTAL FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF
#10NEW CRYSTAL FORM OF NITROGEN-CONTAINING TRICYCLIC COMPOUND AND USE THEREOF
#11MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES
#12Compound For Use In Treating Narcolepsy
#13COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
#14PRISTINAMYCIN IA AND FLOPRISTIN COMBINATIONS IN TREATING OR PREVENTING BACTERIAL INFECTIONS
#15QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF
#16NEW CRYSTAL FORM AND USE OF NITROGENOUS TRICYCLIC COMPOUND
#17HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF
#18TAAR1 AND SEROTONIN MODULATORS, AND PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
#19COMPOUNDS
#20BENZOTHIAZOLE AND QUINOLINE DERIVATIVES FOR USE IN TREATING KAWASAKI DISEASE
#21MEDICAMENT
#22INHIBITORS OF NLRP3 INFLAMMASOME
#23INHIBITORS OF NLRP3 INFLAMMASOME
#24METHODS AND COMPOUNDS FOR TREATMENT OF AUTISM SPECTRUM DISORDER
#25CHEMICAL SYNTHESIS OF CLOPIDOGREL ACTIVE METABOLITES AND DISULFIDE CONJUGATE PRODRUGS
#26USE OF CD83 IN COMBINATION THERAPIES
#27BENZOTHIAZOLE DERIVATIVES AND 7-AZA-BENZOTHIAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF
#28METHODS OF TREATING OR PREVENTING VIRAL INFECTION WITH FLUORINATED AlphaV INTEGRIN ANTAGONISTS
#29Pemafibrate dosing regimens
#30METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS
#31COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN INHIBITORS
#32COMBINATIONS
#33COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#34ROR Gamma T Inhibitors and Topical Uses Thereof
#35COMBINATION THERAPY FOR CANCER
#36SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#37Pemafibrate dosing regimens
#38NOVEL USE
#39COMBINATION
#40Pemafibrate dosing regimens
#41Fused Imidazole Derivatives as IL-17 Modulators
#42COMPOSITION COMPRISING CLAY MINERAL COMPLEX FOR PREVENTION, ALLEVIATION, AND TREATMENT OF INFLAMMATORY BOWEL DISEASE, PREPARATION METHOD FOR COMPOSITION, AND METHOD FOR ALLEVIATION AND TREATMENT FOR INFLAMMATORY BOWEL DISEASE
#43COMPOSITION FOR ORAL ADMINISTRATION WITH CONTROLLED RELEASE PROPERTIES COMPRISING COMPLEX OF CLAY MINERALS, METHOD FOR PREPARING SAME, AND METHOD FOR CONTROLLING RELEASE PROPERTIES
#44Compounds that participate in cooperative binding and uses thereof
#45BENZOTHIAZOLE DERIVATIVES AND 7-AZA-BENZOTHIAZOLE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF
#46Heterocycle amines and uses thereof
#47MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#48MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#49BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD
#50COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISORDERS
#51SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#52PHARMACEUTICAL FORMULATIONS
#53Compositions, uses and methods for making them
#54MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#55Azaindole derivatives and their use as ERK kinase inhibitors
#56Hybrid cyclic libraries and screens thereof
#57PHARMACEUTICAL FORMULATIONS
#58Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs
#59COMPOSITIONS AND METHODS FOR TREATING CANCER
#60Cross-linked fatty acid-based biomaterials
#61SUPER-OXIDE DISMUTASE MIMETICS
#62Sulfur (VI) fluoride compounds and methods for the preparation thereof
#63Compounds that participate in cooperative binding and uses thereof
#64Antibacterial compounds and methods of use thereof
#65Arylfluorosulfate compounds and methods
#66Methods for treating diseases and nerve injuries
#67Heterocycle amines and uses thereof
#68MEDICAMENT
#69Antifibrotic compounds and uses thereof
#70Hybrid cyclic libraries and screens thereof
#71PHARMACEUTICAL FORMULATIONS
#72SUPER-OXIDE DISMUTASE MIMETICS
#73Nitrogen-containing tricyclic compounds and uses thereof in medicine
#74ARYLFLUOROSULFATE COMPOUNDS AND METHODS
#75Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#76Fatty-acid based particles
#77Antibacterial compounds and methods of use thereof
#78Sulfur(VI) fluoride compounds and methods for the preparation thereof
#79EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF A KIDNEY TRANSPLANT
#80Heterocycle amines and uses thereof
#81Octahydropyrrolopyrroles their preparation and use
#82MAPC treatment of brain injuries and diseases
#83Compounds that participate in cooperative binding and uses thereof
#84Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51
#85Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors
#86Hybrid cyclic libraries and screens thereof
#87Compounds for the treatment of cancer
#88MAPC treatment of brain injuries and diseases
#89CGAS in systemic lupus erythematosus (SLE)
#90Cross-linked fatty acid-based biomaterials
#91Tricyclic compounds and uses thereof in medicine
#92Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#93Flap modulators
#94Sulfur(VI) fluoride compounds and methods for the preparation thereof
#951-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
#96Bromodomain inhibitors
#97Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
#98Heterocycle amines and uses thereof
#99Fatty-acid based particles
#100ANTI-GLUCAGON RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF
#101Super-oxide dismutase mimetics
#102Treatment of synucleinopathies
#1034-amino-6-(2,6-dichlorophenyl)-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8H)-one derivatives, synthesis and uses thereof
#104Hybrid cyclic libraries and screens thereof
#1051-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
#106Triazine derivatives
#107Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
#108Inhibitors of the renal outer medullary potassium channel
#109Tricyclic compound
#110FUSED HETEROCYCLIC COMPOUND AND USE THEREOF
#111THIADIAZOLE ANALOGS THEREOF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED-CONDITIONS
#112Cross-linked fatty acid-based biomaterials
#113Compositions including triciribine and methods of use thereof
#114Methods for treating HCV
#115Triazine derivatives
#1167-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders
#117Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
#118ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE
#119Thermogel formulation for combination drug delivery
#1202,4-pyrimidinediamine compounds and uses as anti-proliferative agents
#121Antifibrotic compounds and uses thereof
#1221-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
#123Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting
#124Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#125Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
#126Antioxidant small molecules aimed at targeting metal-based oxidative stress in neurodegenerative disorders
#127Bicyclic carboxamide inhibitors of kinases
#128Anti-inflammation compounds
#129Heterocycle amines and uses thereof
#130Therapeutic particles suitable for parenteral administration and methods of making and using same
#131Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
#132Tazobactam arginine compositions
#133Hybrid cyclic libraries and screens thereof
#134Use of CD83 in combination therapies
#135Fused heterocyclic compounds
#136Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof
#137Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators
#138Treatment of synucleinopathies
#139Cellulosic gel material as a pharmaceutical excipient
#140CCR1 INHIBITORS USEFUL FOR THE TREAMENT OF MULTIPLE MYELOMA AND OTHER DISORDERS
#141BIARYL COMPOUNDS AND METHODS OF USE THEREOF
#142QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#143QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#1441-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
#145PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, OR REVERSING NEURONAL DYSFUNCTION
#146ANALGESIC COMBINATION OF OPIOID ANALGESIC AND CYCLOOXYGENASE-2 INHIBITOR
#147USE OF GYMNODIMINE, ANALOGUES AND DERIVATIVES FOR THE TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASES ASSOCIATED WITH TAU AND B-AMYLOID
#148Topical compositions comprising ascomycins
#149Fused heterocyclic compound and use thereof
#150CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES
#151BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN
#152METNASE AND INTNASE INHIBITORS AND THEIR USE IN TREATING CANCER
#153Extended-release oral dosage forms for poorly soluble amine drugs
#154Bone Modulators And Methods Therewith
#155Compositions and methods for treating cancer
#156Fused heterocyclic compounds
#157HIV integrase inhibitors
#158ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE
#159Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
#160Tricyclic compound
#1612,4-pyrimidinediamine compounds and uses as anti-proliferative agents
#162Method of treating mantle cell lymphoma
#163CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS
#164BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN
#165IMIDAZOLE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M3
#166Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
#167COMPOUNDS AND METHODS OF TREATMENT
#168Treatment of synucleinopathies
#169MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#170Super-oxide dismutase mimetics
#171NEUROTHERAPEUTIC COMPOSITION AND METHOD THEREFOR
#172Fatty-acid based particles
#173Therapeutic particles suitable for parenteral administration and methods of making and using same
#174Polymorphisms in voltage-gated sodium channel alpha 1-subunit as markers for therapy selection
#175METHOD OF TREATING AUTOIMMUNE DISEASES
#176Quinoline Derivatives as Antibacterial Agents
#177HIV integrase inhibitors
#178Carboline derivatives useful in the inhibition of angiogenesis
#179Beloxepin and analogs for the treatment of pain
#180Hydrophilic foam and pharmaceutical dosage form employing the same
#181COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT
#182TOPICAL FORMULATIONS
#183COMPOUNDS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES
#184Integrase Inhibitors 3
#185MAPC therapeutics without adjunctive immunosuppressive treatment
#186Local Delivery of PAR-1 Antagonists to Treat Vascular Complications
#187CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders
#188THERAPIES FOR COGNITION AND LEARNING ENHANCEMENT
#189BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN
#190Administration of carboline derivatives useful in the treatment of cancer and other diseases
#191Cross-linked fatty acid-based biomaterials
#192PGD2 receptor antagonists for the treatment of inflammatory diseases
#193Treating unwanted ocular conditions using an ascomycin macrolactam
#194Fused heterocyclic compound and use thereof
#195Bridged polycyclic compound based compositions for coating oral surfaces in humans
#196USE OF COMPOSITIONS TO ENHANCE INNATE IMMUNE RESPONSE
#197Compounds and compositions for treating infection
#198HIV integrase inhibitors
#199Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction
#200Biocompatible Polymer System for Extended Drug Release
#201Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
#202Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
#203Treatments of therapy resistant diseases and drug combinations for treating the same
#204Pharmacokinetics of protease inhibitors and other drugs
#205TELOMERE TARGETING AGENTS AS STEM CELLS DIRECTED TREATMENTS
#206Compounds and Methods of Treatment
#207Glutathione peroxidase mimetics for the treatment of dermatoses
#208Neurotherapeutic compositions and method
#209Semi-fluorinated block copolymers for delivery of therapeutic agents
#210ASSOCIATION OF BETA3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC USE THEREOF
#211Identification and use of agents that modulate oncogenic transcription agent activity
#212Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors
#213COMBINATION THERAPY FOR THE TREATMENT OF PAIN
#214Anti-cancer combinations
#215Anti-cancer combinations
#216Anti-cancer combinations
#217Anti-cancer combinations
#218Analgesic combination of tramadol and meloxicam
#2192,4-pyrimidinediamine compounds and uses as anti-proliferative agents
#2202,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents
#2212,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents
#222Polycyclic agents for the treatment of respiratory syncytial virus infections
#223Administration of carboline derivatives useful in the treatment of cancer and other diseases
#224Abnormal cannabidiols as agents for lowering intraocular pressure
#225Neurotherapeutic composition and method therefor
#226Polymorphisms in voltage-gated sodium channel α 1-subunit as markers for therapy selection
#227Therapeutic combinations for the treatment or prevention of psychotic disorders
#228Agents for Regulating Adiponectin Receptor Expression
#229RSV POLYMERASE INHIBITORS
#230COMBINATION OF A CB1 RECEPTOR ANTAGONIST AND OF A PRODUCT WHICH ACTIVATES DOPAMINERGIC NEUROTRANSMISSION IN THE BRAIN, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF PARKINSON'S DISEASE
#231Analgesic combination of oxycodone and celecoxib
#232Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
#233Therapeutic methods
#234Compositions for treating angina
#235Controllable drug releasing gradient coatings for medical devices
#236Anti-cancer combinations
#237Receptor agonists
#238Method of treating autoimmune diseases
#239Tricyclic compound, process for producing the same, and use
#240PGD2 receptor antagonists for the treatment of inflammatory diseases
#241Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases
#242Topical compositions comprising ascomycins
#243Method of treating autoimmune diseases
#244Carboline derivatives useful in the treatment of cancer
#245Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
#246RSV polymerase inhibitors
#247Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
#248Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
#249Solid compositions containing compounds unstable to oxygen and method for stabilization thereof
#250Method of treating mantle cell lymphoma
#2512,4-pyrimidinediamine compounds and uses as anti-proliferative agents
#252Carbacephem β-lactam antibiotics